Differential methylation of DAZAP2 promoter region was shown to regulate its expression in multiple myeloma cell lines103, and its decreased expression levels were found to contribute to pathogenesis of this cancer104. This evidence concerns the gene DAZAP2 and plasma cell myeloma.